Americans Are Dying in the Pandemic at Rates Far Higher Than in Other Countries
ANGLO AMERICA, 19 Oct 2020
13 Oct 2020 – During this pandemic, people in the United States are dying at rates unparalleled elsewhere in the world.
A new report in the Journal of the American Medical Association finds that in the past five months, per capita deaths in the U.S., both from COVID-19 and other causes, have been far greater than in 18 other high-income countries.
“It’s shocking. It’s horrible,” says Dr. Ezekiel J. Emanuel, a professor of health policy and medical ethics at the University of Pennsylvania and one of the authors of the study.
“The United States really has done remarkably badly compared to other countries,” he says. “I mean, remarkably badly.”
The study looks at per capita death rates in 2020 in 18 countries with populations larger than 5 million people and per capita gross domestic product levels above $25,000 per year. It breaks out deaths attributed to COVID-19 and examines how total deaths in the U.S. are higher than normal this year. This so-called “all-cause” mortality takes into account fatalities that may have been due to the coronavirus but were never confirmed or were due to other factors such as people not seeking medical care during the crisis.
Overall deaths in the United States this year are more than 85% higher than in places such as Germany, Israel and Denmark after adjusting for population size. Deaths in the U.S. are 29% higher than even in Sweden, “which ignored everything for so long,” Emanuel says. Sweden made a point of refusing to order strict social restrictions and never went in to a full lockdown. “We have 29% more mortality than we should have if we’d followed Sweden’s path and Sweden virtually did nothing.”
Even looking just at confirmed COVID-19 deaths, the number of people dying since May 10 — again after adjusting for population size — is on average 50% higher than every other country in the study. In addition, the rate people are dying in the U.S. has stayed far above everywhere else. Emanuel says the current elevated mortality rates are important because they eliminate the chaotic early months of the pandemic when testing, treatment and reporting varied dramatically around the globe.
The rate of COVID-19 deaths in the U.S. since June 7 is 27.2 per 100,000 people. In contrast, in Italy, the death rate is down to 3.1 per 100,000.
“It’s not like Italy has some secret medicine that we don’t,” Emmanuel says. “They’ve got the same public health measures we’ve got. They just implemented them effectively and we implemented them poorly.” If the U.S. had managed to keep its per capita death rate at the level of Italy’s, 79,120 fewer Americans would have died.
This study is important for illustrating just how bad the death rate from COVID-19 has been in the U.S. compared with in other countries, says Theo Vos, a professor at the Institute for Health Metrics and Evaluation at the University of Washington in Seattle.
“The U.S. is in the company of a few other countries with very high rates of deaths assigned to COVID,” says Vos who was not involved in the study. “Only Belgium looks worse.” But he points out that once you look past the initial phase of the outbreak, the U.S. ends up looking worse than Belgium.
“Early on in the epidemic, many countries had a lack of testing possibilities. And a lot of deaths occurred early on where there was no formal diagnosis,” he says. “So Belgium decided ‘we’re going to count all of them.’ While in other countries like the Netherlands or the U.K. and the U.S. quite a few deaths have not been recognized as COVID.”
He says this is why looking at overall deaths since the start of the pandemic, not just official COVID-19 deaths, is important. On that measure, the U.S. is now consistently reporting roughly 25% more deaths than these other wealthy nations.
Vos is from the Netherlands, and even though he works for the University of Washington, he recently moved back. He says looking at how death rates are changing over time is important because this pandemic is far from over.
“I now live in a country that’s seeing the biggest increase in the number of cases of almost any place in the world currently,” he says. Second waves of infections are hitting many places in Europe right now including France, Spain, Belgium and the U.K. Vos expects this to get even worse as more people spend more time indoors in the colder months.
He says there has also been a lot of complacency in Europe. “Here in the Netherlands, there is an appalling low acceptance of masks,” he says. “Only in the last week, I’ve started seeing other people in the supermarket wearing a mask. I used to be the only one.”
So while the U.S. death rates so far have been much higher than most other wealthy countries, Vos says, that could change as this pandemic continues to ebb and surge in various parts of the world.
Jason Beaubien is NPR’s Global Health and Development Correspondent on the Science Desk. In this role, he reports on a range of issues across the world. He’s covered the plight of Rohingya refugees in Bangladesh, mass cataract surgeries in Ethiopia, abortion in El Salvador, poisonous gold mines in Nigeria, drug-resistant malaria in Myanmar and tuberculosis in Tajikistan. He was part of a team of reporters at NPR that won a Peabody Award in 2015 for their extensive coverage of the West Africa Ebola outbreak.
Tags: Airborne contagion, Anglo America, COVID-19, China, Community, Compassion, Coronavirus, Cuba, Economy, Empathy, Environment, Health, Lockdown, Orthomolecular Medicine, PCR Tests, Pandemic, Public Health, Research, Science, Science and Medicine, Swiss Policy Research, USA, United Nations, WHO
DISCLAIMER: The statements, views and opinions expressed in pieces republished here are solely those of the authors and do not necessarily represent those of TMS. In accordance with title 17 U.S.C. section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. TMS has no affiliation whatsoever with the originator of this article nor is TMS endorsed or sponsored by the originator. “GO TO ORIGINAL” links are provided as a convenience to our readers and allow for verification of authenticity. However, as originating pages are often updated by their originating host sites, the versions posted may not match the versions our readers view when clicking the “GO TO ORIGINAL” links. This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner.
Join the discussion!
We welcome debate and dissent, but personal — ad hominem — attacks (on authors, other users or any individual), abuse and defamatory language will not be tolerated. Nor will we tolerate attempts to deliberately disrupt discussions. We aim to maintain an inviting space to focus on intelligent interactions and debates.
Click here to go to the current weekly digest or pick another article: